Zyus Life Sciences Corp competitors & alternatives

Helus Pharma Inc.PharmaceuticalsUnited States

67% match

Similar pharmaceuticals company

Helus Pharma Inc. advances mental health treatments by developing novel, second-generation therapies, proprietary drug delivery systems, and patent-protected molecules. The company serves the healthcare and pharmaceutical sectors.

Pharmaceuticals & Biotechnology

Nascent Pharma Holdings, Inc. is a pharmaceutical intellectual property holding company that owns and monetizes patents for high-purity liquid cannabinoid formulations. The company serves the health, wellness, cannabis, and medical industries by licensing its proprietary technology for pain management and neurological disorder treatments.

Mindset Pharma Inc.PharmaceuticalsCanada

65% matchPrivate

Similar pharmaceuticals company

Mindset Pharma Inc. is a drug discovery and development company based in Toronto, Canada, focused on creating optimized, patentable next-generation psychedelic medicines.

Cannabinoid API Solutions, LLCPharmaceuticals & BiotechnologyUnited States

65% matchPrivate

Pharmaceuticals & Biotechnology

Cannabinoid API Solutions, LLC provides hemp-derived cannabinoid active pharmaceutical ingredients, such as Cannabidiol (CBD) and Cannabigerol (CBG), for the pharmaceutical and nutraceutical industries. The company supplies ultra-pure and natural ingredients tailored for the CBD pharmaceutical market.

Similar pharmaceuticals company

InMed Pharmaceuticals Inc. operates as a clinical-stage pharmaceutical firm, concentrating its efforts on the investigation and creation of therapeutic solutions derived from cannabinoids. Its primary product, INM-755, is a cannabinol-infused topical cream that is currently progressing through its second Phase I clinical trial for the management of epidermolysis bullosa. Beyond this lead candidate, the company is also developing INM-088, which is undergoing preclinical studies for glaucoma treatment, and INM-405, intended for pain relief. Its broader development pipeline encompasses cannabinoid-based interventions for a variety of medical conditions, with a particular focus on dermatological and ocular disorders. Furthermore, InMed is involved in critical IND-enabling pharmacology and preclinical toxicology research. It is also pioneering IntegraSyn, an innovative integrated biosynthesis approach designed to produce pharmaceutical-grade cannabinoids efficiently. The company maintains a research partnership with BayMedica Inc. to collaborate on the formulation and assessment of novel cannabinoid therapeutics. Established in 1981, the company is headquartered in Vancouver, Canada. It operated under the name Cannabis Technologies Inc. before officially rebranding as InMed Pharmaceuticals Inc. in October 2014.

NYB Holdings LtdNYB · Biotechnology & PharmaceuticalsUnited States

65% matchPublic

Biotechnology & Pharmaceuticals

NYB Holdings Ltd operates an AI-first drug discovery and biotechnology platform that utilizes a large natural compound library and predictive modeling to identify bioactive compounds. The company develops science-backed wellness solutions for nutraceutical applications and advances high-potential drug candidates into preclinical development for the pharmaceutical industry.

Similar pharmaceuticals company

Raphael Pharmaceutical Inc. operates as a biopharmaceutical firm, concentrating its efforts on discovering and clinically developing novel therapeutic solutions. These treatments primarily leverage cannabinoids and are designed to enhance patients' quality of life. Currently, the company's leading investigational drug candidate is being advanced for the management of rheumatoid arthritis. Furthermore, Raphael Pharma plans to broaden its pipeline to include more cannabinoid-based medicines aimed at various cancer types and other autoimmune conditions. The company's corporate headquarters are situated in Tel Aviv-Jaffa, Israel.

Pharmaceuticals, Biotechnology & Life Sciences

Tryptamine Therapeutics Limited is a public pharmaceuticals, biotechnology, and life sciences company based in Australia, trading under the ticker TYP.

HLS Therapeutics Inc.HLS · PharmaceuticalsEtobicoke, Canada

64% matchPublic

Similar pharmaceuticals company

HLS Therapeutics Inc. operates as a specialized pharmaceutical firm, concentrating on the acquisition and commercialization of medicinal products, primarily within the niche central nervous system (CNS) and cardiovascular (CV) sectors. Its reach extends across Canada, the United States, and international markets. The company's core product lineup includes Clozaril, an atypical antipsychotic used in the treatment of schizophrenia; Vascepa, an icosapent ethyl capsule formulation; and PERSERIS, an injectable risperidone product for treating schizophrenia. Additionally, HLS offers MyCare psychiatry laboratory assays and MyCare Insite tests for point-of-care therapeutic drug-level monitoring. Furthermore, the company possesses U.S. marketing privileges for Absorica, a commercial-stage dermatology solution, and Canadian rights for Trinomia, a cardiovascular therapeutic. It also manages a portfolio of royalty interests from four distinct healthcare products. Founded in 2018, HLS Therapeutics Inc. is based in Etobicoke, Canada.

Similar pharmaceuticals company

Echo Pharmaceuticals is an innovative technology-based pharmaceutical company headquartered in Leiden, Netherlands, recognized for its expertise in cannabinoid-based therapeutics.

Similar pharmaceuticals company

CV Sciences, Inc. functions as a life sciences organization primarily operating across North America. Its business activities are organized into two distinct divisions: Consumer Products and Specialty Pharmaceutical. The Consumer Products division focuses on the creation, manufacturing, and commercialization of plant-derived dietary supplements and cannabidiol (CBD) products sourced from hemp. These offerings are marketed under various brand identities including PlusCBD, ProCBD, HappyLane, CV Acute, CV Defense, and PlusCBD Pet. They serve a wide array of health and wellness sectors such as nutraceuticals, personal care, specialty food items, and pet products. The company distributes these goods through its own digital platforms, other online retailers, a network of chosen distributors, and traditional brick-and-mortar stores. In contrast, the Specialty Pharmaceutical division is dedicated to the research, advancement, and eventual market launch of cannabinoids for the treatment of specific medical conditions. A key project in this segment involves the drug candidate CVSI-007, an innovative combination of CBD and nicotine designed to combat smokeless tobacco use and dependence. Established in 2010, the company was initially known as CannaVest Corp. before officially adopting the name CV Sciences, Inc. in January 2016. Its main corporate offices are located in San Diego, California.

Entos PharmaceuticalsBiotech, PharmaceuticalsCanada

64% matchPrivate

Biotech, Pharmaceuticals

Entos Pharmaceuticals Inc. is a clinical-stage genetic medicines company headquartered in Edmonton, Canada, specializing in the development of innovative delivery systems for genetic therapies.